Lon T. Spada,Jane-Gou Shiah,Patrick M. Hughes,Thomas C. Malone,Gerald W. Devries,Jeffrey L. Edelman,Julie A. Wurster,Xialing Guo,Sougato Boral
申请号：
US13908741
公开号：
US20130267497A1
申请日:
2013.06.03
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to drug delivery systems comprising ocular implant, which include organic molecules, capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation, in combination with a polymer, which polymer serves to control, modify, modulate and/or slow the release of the therapeutic component into the environment of the eye in which said composite is placed.
